IL6 and Alzheimer disease: Figure 4 shows that the levels of IL-1β, IL-6 (p < 0.05), TNOS and iNOS were significantly increased (p < 0.01) in the ADM group compared with the BLA group, indicating that the levels of pro-inflammatory factors in the ADM group were increased, which aggravated the development of AD.